Norman Zamcheck

Title: Norman Zamcheck: Innovator in Colorectal Carcinoma Diagnostics

Introduction

Norman Zamcheck is a distinguished inventor based in W. Newton, MA, who has made significant contributions to medical diagnostics through his innovative work on monoclonal antibodies. With a focus on colorectal carcinoma, his research represents a vital advancement in the detection and monitoring of this prevalent cancer.

Latest Patents

Norman Zamcheck holds one patent for his groundbreaking work titled "Monoclonal antibody for colorectal carcinoma." This patent features an antibody, ND4, specifically raised to react with a new tumor marker—a glycoprotein of approximately 160 kD—which is present on the surface of undifferentiated colorectal carcinoma cells. Notably, this antibody does not cross-react with other known tumor markers, making it a unique and valuable tool in the diagnosis and monitoring of colorectal carcinoma.

Career Highlights

Throughout his career, Norman Zamcheck has worked with esteemed institutions such as the New England Deaconess Hospital Corporation and the Mallory Institute of Pathology Foundation. His experiences in these organizations have equipped him with the expertise required to develop innovative solutions for complex medical challenges.

Collaborations

During his impactful career, Zamcheck has collaborated with notable individuals, including Ronald R. Salem and Peter Thomas. These partnerships have contributed to the advancement of research within the field, facilitating the development of effective diagnostic tools for colorectal cancer.

Conclusion

Norman Zamcheck's contributions to the medical field through his patent on a monoclonal antibody for colorectal carcinoma highlight his dedication to improving cancer diagnosis and treatment. His work not only reflects his innovative spirit but also emphasizes the importance of research and collaboration in advancing healthcare solutions.